Provectus Biopharmaceuticals, Inc. v. Rsm US LLP

2018 NCBC 100
CourtNorth Carolina Business Court
DecidedSeptember 28, 2018
Docket17-CVS-10396
StatusPublished

This text of 2018 NCBC 100 (Provectus Biopharmaceuticals, Inc. v. Rsm US LLP) is published on Counsel Stack Legal Research, covering North Carolina Business Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Provectus Biopharmaceuticals, Inc. v. Rsm US LLP, 2018 NCBC 100 (N.C. Super. Ct. 2018).

Opinion

Provectus Biopharmaceuticals, Inc. v. RSM US LLP, 2018 NCBC 100.

STATE OF NORTH CAROLINA IN THE GENERAL COURT OF JUSTICE SUPERIOR COURT DIVISION MECKLENBURG COUNTY 17 CVS 10396

PROVECTUS BIOPHARMACEUTICALS, INC.,

Plaintiff, ORDER AND OPINION ON v. DEFENDANT’S MOTION TO DISMISS

RSM US LLP f/k/a McGLADREY, LLP,

Defendant.

1. THIS MATTER is before the Court upon Defendant RSM US LLP f/k/a

McGladrey, LLP’s (“RSM”) Motion to Dismiss Plaintiff Provectus

Biopharmaceuticals, Inc.’s (“Provectus”) Amended Complaint under Rule 12(b)(6) of

the North Carolina Rules of Civil Procedure (the “Motion”).

2. Having considered the Motion, the briefs and supplemental briefs in support

of and in opposition to the Motion, and the arguments of counsel at the hearing on

the Motion, the Court hereby GRANTS in part and DENIES in part the Motion.

Baker, Donelson, Bearman, Caldwell & Berkowitz, PC, by Mark D. Griffin, Lori H. Patterson, Matthew G. White, and R. Andrew Hutchinson, and Erwin, Bishop, Capitano & Moss, P.A., by A. Todd Capitano, for Plaintiff Provectus Biopharmaceuticals, Inc.

Williams & Connolly LLP, by Thomas H. Selby, Jessica Richard, and Amy B. McKinlay, and Poyner Spruill LLP, by Karen H. Chapman, Cynthia L. Van Horne, and Lee A. Spinks, for Defendant RSM US LLP f/k/a McGladrey LLP.

Bledsoe, Chief Judge. I.

FACTUAL BACKGROUND

3. The Court does not make findings of fact when ruling on a motion to dismiss

under Rule 12(b)(6). See, e.g., Concrete Serv. Corp. v. Inv’rs Grp., Inc., 79 N.C. App.

678, 681, 340 S.E.2d 755, 758 (1986). Rather, the Court recites the relevant

allegations in the pleading asserting the challenged claims—here, Provectus’s

Amended Complaint.

4. Provectus is a publicly traded, development-stage biotechnology company

with its principal place of business in Knoxville, Tennessee. (Am. Compl. ¶¶ 1, 14,

ECF No. 24.) Provectus was founded in 2002 and focuses on developing drugs for

certain cancers and skin conditions. (Am. Compl. ¶ 19.) At all relevant times,

Provectus had four employees. (Am. Compl. ¶ 20.)

5. Defendant RSM is an Iowa limited liability partnership with its principal

place of business in Illinois. (Am. Compl. ¶ 15.) RSM is the United States-based firm

within RSM International, a global network of independent audit, tax, and consulting

firms. (Am. Compl. ¶ 15.) RSM holds itself out as a leading provider of auditing, tax,

wealth management, and consulting services. (Am. Compl. ¶ 15.) RSM is registered

to conduct business in North Carolina and conducted its primary services at issue

here through its North Carolina offices and personnel. (Am. Compl. ¶ 15.)

6. The present dispute between these two companies involves Provectus’s

contention that two of its executives received millions of dollars in wrongful reimbursement payments as the result of intentional, willful, or negligent actions

RSM took in the course of providing accounting or auditing services to Provectus.

7. In 2007, RSM approached Provectus, marketing itself as a “one-stop

resource for all of Provectus’s accounting and financial needs.” (Am. Compl. ¶ 21.)

Provectus decided to hire RSM because, with only four employees, Provectus lacked

the internal resources or ability to manage and monitor its own financial and

accounting systems. (Am. Compl. ¶¶ 20, 22.)

8. Beginning in 2007 and continuing through early 2016, RSM maintained

three separate engagements with Provectus. (Am. Compl. ¶¶ 2–3.) The different

engagements can be summarized as follows:

(1) An outsourcing engagement, under which RSM provided comprehensive accounting services, human resources services, related technology services, and business consulting services;

(2) An engagement for review of [Provectus’s] financial statements, under which RSM advised on Form 10-K and Form 10-Q reporting requirements, reviewed financial statements for compliance with SEC rules and regulations, advised on specific footnote disclosures, advised on various technical accounting matters, and assisted with responding to the SEC on any comment letters relating to technical accounting matters; and

(3) An engagement to provide internal audit and Sarbanes-Oxley (“SOX”) compliance services, under which RSM directed [Provectus’s] compliance with SOX Section 404, including the utilization of integrated risk management services to plan and conduct a Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) evaluation, to design and assess the effectiveness of [Provectus’s] internal controls, and to assess operating effectiveness of [Provectus’s] internal controls.

(Am. Compl. ¶¶ 2, 22.) As a result of these engagements, Provectus alleges that RSM

had “direct access to and day-to-day control over every aspect of Provectus’s financial and accounting systems from 2007 until early 2016, including complete control over

the management of [Provectus’s] general ledger.” (Am. Compl. ¶ 23.)

9. As a particular part of its duties connected to its SOX compliance services

“RSM developed, drafted, reviewed, and commented on the development of

Provectus’s internal controls environment, including Provectus’s Purchase to Pay

Process [Narrative].” (Am. Compl. ¶ 29.) This Purchase to Pay Process Narrative

dealt with “the processes and responsibilities for reviewing, processing, and

approving [Provectus] expenditures.” (Am. Compl. ¶ 30.) These expenditures

included advances and reimbursements for travel and entertainment (“T&E”)

expenses incurred by Provectus employees. (Am. Compl. ¶¶ 30–35.)

10. Under the Purchase to Pay Process Narrative, Provectus employees could

receive wire transfer advances to cover future travel costs purportedly associated

with Provectus. (Am. Compl. ¶ 49.) The process for advancing and documenting

these wire transfers required the approval of key Provectus personnel:

The CFO determines the need for a wire and completes the Wire Backup Form. This form is then signed by 2 of the 3 [Provectus] founders and the form is faxed to the bank for completion. The Wire Backup Form is attached to the Bank Confirmation and the CFO prepares the journal entry to record the transaction and forwards to [RSM] for posting. In addition, a copy of the transaction is given to the [Bible Harris Smith PC (“BHS”)] staff member to make sure it is included properly on the reconciliation and processed in QuickBooks.1

1 BHS was a CPA firm “retained by Provectus to provide data processing assistance within the accounting department and to prepare Provectus’s Federal Income Tax Returns.” (Am. Compl. 10 n.2.) (Am. Compl. ¶ 35.) As part of this process, RSM received the advance requests and

the necessary officer approval for the wire transfers. (Am. Compl. ¶ 49.)

11. The Purchase to Pay Process Narrative also allowed Provectus employees

to be reimbursed for legitimate business expenses. (Am. Compl. ¶ 49.) This process

worked as follows:

Each employee prepares an itemized listing of expenses, attaches the support for each item and signs. This Expense Report is then forwarded through the CFO to the BHS Staff member who reviews the document for accuracy and completeness of backup and amounts. If there are problems these are discussed and resolved with the applicable employee and once final, they are signed off by the BHS staff and process[ed] as any other invoice.

(Am. Compl. ¶ 31.) As part of the reimbursement process, RSM received an expense

reimbursement request and any paperwork submitted therewith. (Am. Compl. ¶ 49.)

12.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Charles W. Cooper v. United States
442 F.2d 908 (Seventh Circuit, 1971)
Swain v. Preston Falls East, L.L.C
576 S.E.2d 699 (Court of Appeals of North Carolina, 2003)
Farndale Co., LLC v. Gibellini
628 S.E.2d 15 (Court of Appeals of North Carolina, 2006)
Hall v. SINCLAIR REFINING COMPANY
89 S.E.2d 396 (Supreme Court of North Carolina, 1955)
Electro Lift, Inc. v. Miller Equipment Co.
166 S.E.2d 454 (Court of Appeals of North Carolina, 1969)
Barger v. McCoy Hillard & Parks
488 S.E.2d 215 (Supreme Court of North Carolina, 1997)
Rodgers Builders, Inc. v. McQueen
331 S.E.2d 726 (Court of Appeals of North Carolina, 1985)
Barrett Kays & Associates, P.A. v. Colonial Building Co.
500 S.E.2d 108 (Court of Appeals of North Carolina, 1998)
Ragsdale v. Kennedy
209 S.E.2d 494 (Supreme Court of North Carolina, 1974)
Hudson-Cole Development Corp. v. Beemer
511 S.E.2d 309 (Court of Appeals of North Carolina, 1999)
Harris v. NCNB National Bank of North Carolina
355 S.E.2d 838 (Court of Appeals of North Carolina, 1987)
Yancey v. Lea
550 S.E.2d 155 (Supreme Court of North Carolina, 2001)
Good Hope Hospital, Inc. v. North Carolina Department of Health & Human Services
620 S.E.2d 873 (Court of Appeals of North Carolina, 2005)
Fulton v. Vickery
326 S.E.2d 354 (Court of Appeals of North Carolina, 1985)
Carver v. Roberts
337 S.E.2d 126 (Court of Appeals of North Carolina, 1985)
Sutton v. Duke
176 S.E.2d 161 (Supreme Court of North Carolina, 1970)
Shepard v. Ocwen Federal Bank, FSB
638 S.E.2d 197 (Supreme Court of North Carolina, 2006)
Watts v. Cumberland County Hospital System, Inc.
343 S.E.2d 879 (Supreme Court of North Carolina, 1986)
Torres v. McClain
535 S.E.2d 623 (Court of Appeals of North Carolina, 2000)
Reich v. Price
429 S.E.2d 372 (Court of Appeals of North Carolina, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
2018 NCBC 100, Counsel Stack Legal Research, https://law.counselstack.com/opinion/provectus-biopharmaceuticals-inc-v-rsm-us-llp-ncbizct-2018.